| Catalog_no |
ADMC0956 |
| Product_name |
Delanzomib(CEP-18770) |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
2560.00/7220.00/10660.00 |
| Specificity |
Target: Proteasome . Fields: Delanzomib(CEP-18770) is a novel orally-active inhibitor of the chymotrypsin-like activity of the proteasome that down-modulates the nuclear factor-kappaB (NF-kappaB) activity. |
| Purification |
>98% |
| Concentration |
靶点：Proteasome;IC50：No data |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
CEP-18770,CEP 18770,CEP18770 |
| Molecular Weight |
413.28 |
| Notes |
Delanzomib(CEP-18770) is a novel orally-active inhibitor of the chymotrypsin-like activity of the proteasome that down-modulates the nuclear factor-kappaB (NF-kappaB) activity. |
| Instructions |
 查看与下载 |
